KOREA WHO
-
-
CEO and President of Lotte Biologics
Park James Jong Eun
15 Years Global Sales, Ex-Samsung VP Leads Lotte Biologics Orders
-
Last Updated on Aug 8, 2025
Copy Url : https://www.koreawho.com/profile/ParkJamesJongEun
-
CEO and President of Lotte Biologics
- Life Summary
Park James Jong Eun is the CEO and President of Lotte Biologics.
He is focusing his efforts on building the Songdo campus and securing new clients for the company’s contract development and manufacturing organization (CDMO) business.
Born in 1966, he earned a bachelor’s degree in chemical engineering from the University of California, Davis, and a master’s degree in industrial engineering from Columbia University.
After working at global pharmaceutical giants Merck and Bristol Myers Squibb (BMS), he joined Samsung Biologics in 2016.
At Samsung Biologics, he served as Head of the Global Sales Center before moving to GC Cell in 2023 as CEO.
In 2025, he was appointed CEO and President of Lotte Biologics.
#LotteBiologics #CDMO #ParkJamesJongEun #biopharmaceuticals #Songdo #SamsungBiologics #Merck #BristolMyersSquibb #GCCell #leadership
He is focusing his efforts on building the Songdo campus and securing new clients for the company’s contract development and manufacturing organization (CDMO) business.
Born in 1966, he earned a bachelor’s degree in chemical engineering from the University of California, Davis, and a master’s degree in industrial engineering from Columbia University.
After working at global pharmaceutical giants Merck and Bristol Myers Squibb (BMS), he joined Samsung Biologics in 2016.
At Samsung Biologics, he served as Head of the Global Sales Center before moving to GC Cell in 2023 as CEO.
In 2025, he was appointed CEO and President of Lotte Biologics.
#LotteBiologics #CDMO #ParkJamesJongEun #biopharmaceuticals #Songdo #SamsungBiologics #Merck #BristolMyersSquibb #GCCell #leadership
